Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hermann

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 26, 2014
An increase in serum 25-hydroxyvitamin D concentrations preceded a plateau in type 1 diabetes incidence in Finnish childrenMarjaana Mäkinen, Ville Simell, Juha Mykkänen, et al.
Biotechnology and Bioengineering|August 2, 2013
Liquid films on shake flask walls explain increasing maximum oxygen transfer capacities with elevating viscosityHeiner Giese, Amizon Azizan, Anne Kümmel, et al.
Experimental and Molecular Pathology|January 10, 2012
Radiation-induced damage in different segments of the rat intestine after external beam irradiation of the liverSilke Cameron, Antonia Schwartz, Sadaf Sultan, et al.
European Journal of Endocrinology|August 2, 2013
Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunityHeli T Siljander, Robert Hermann, Anne Hekkala, et al.
Clinical Pharmacology and Therapeutics|April 4, 2006
Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activityAnna Westlind-Johnsson, Robert Hermann, Andreas Huennemeyer, et al.
Journal of Clinical Pharmacology|July 31, 2007
The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonideRobert Hermann, Werner Siegmund, Thomas Giessmann, et al.
Cancer|March 13, 2010
A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancerGabriel N Hortobagyi, Robyn R Young, Mark Karwal, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjectsNassr Nassr, Gezim Lahu, Oliver von Richter, et al.
European Journal of Clinical Pharmacology|January 30, 2004
Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposureAlexander Jetter, Martina Kinzig-Schippers, Michael Illauer, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Endocrinology and Metabolism|July 26, 2014
An increase in serum 25-hydroxyvitamin D concentrations preceded a plateau in type 1 diabetes incidence in Finnish childrenMarjaana Mäkinen, Ville Simell, Juha Mykkänen, et al.
Biotechnology and Bioengineering|August 2, 2013
Liquid films on shake flask walls explain increasing maximum oxygen transfer capacities with elevating viscosityHeiner Giese, Amizon Azizan, Anne Kümmel, et al.
Experimental and Molecular Pathology|January 10, 2012
Radiation-induced damage in different segments of the rat intestine after external beam irradiation of the liverSilke Cameron, Antonia Schwartz, Sadaf Sultan, et al.
European Journal of Endocrinology|August 2, 2013
Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunityHeli T Siljander, Robert Hermann, Anne Hekkala, et al.
Clinical Pharmacology and Therapeutics|April 4, 2006
Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activityAnna Westlind-Johnsson, Robert Hermann, Andreas Huennemeyer, et al.
Journal of Clinical Pharmacology|July 31, 2007
The oral, once-daily phosphodiesterase 4 inhibitor roflumilast lacks relevant pharmacokinetic interactions with inhaled budesonideRobert Hermann, Werner Siegmund, Thomas Giessmann, et al.
Cancer|March 13, 2010
A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancerGabriel N Hortobagyi, Robyn R Young, Mark Karwal, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjectsNassr Nassr, Gezim Lahu, Oliver von Richter, et al.
European Journal of Clinical Pharmacology|January 30, 2004
Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposureAlexander Jetter, Martina Kinzig-Schippers, Michael Illauer, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Pageof 12